Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	23.87	65.28	52.71
Graham Fair Price	10.24	12.22	11.08
PEG	129.98	3.30	-1.43
Price/Book	32.22	10.61	8.03
Price/Cash Flow	-581.75	-87.79	-12.88
Prices/Earnings	20.43	52.74	43.80
Price/Sales	33.74	7.00	5.24
Price/FCF	-581.75	-87.79	-12.88
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	4.35	0.11	0.10
Operating Margin	28.45	0.08	0.06
ROA	13.83	< 0.005	< 0.005
ROE	0.05	0.05	9.79
ROIC	0.02	0.02	48.45
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.00	0.28	inf
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.23	0.34	47.90
EPS QOQ	-0.31	0.16	-47.64
FCF QOQ	-9.39	0.80	-91.53
Revenue QOQ	-0.02	0.04	99.02
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	-0.05	-100.00
Days Sales Outstanding (DSO)	45.14	48.03	6.41
Inventory Turnover	0.00	-1802.00	-100.00
Debt/Capitalization	0.76	0.73	-5.16
Quick Ratio	0.87	0.81	-7.49
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	10.91	11.48	5.21
Cash	3.55	1.98	-44.17
Capex	-8.96	-2.64	70.55
Free Cash Flow	-6.80	-1.39	79.59
Revenue	16.72	17.40	4.02
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.00	0.94	-5.97
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	14.07	14.07	< 0.005
Naive Interpretation	Member

06 - Financial Health · Bad

Rating